This text provides a review of the current knowledge in both the mechanics of nourishing the critically ill and the metabolic and immunological roles nutrients play. In-depth chapters discuss disease-related malnutrition as distinct from under-or-over nourishment and the impact of nourishment in either form of malnutrition. The appropriate timing and indications for nutrition support are provided as well as advanced techniques for improving practice. A broad range of issues related to interdisciplinary practice are addressed. Useful for a wide variety of practitioners, including ICU doctors, hospitalists, and nutrition support physicians, Nutrition Support of the Critically Ill provides practical bedside advice and simplified recommendations for practice.
Rezensionen / Stimmen
"This volume in the Nutrition and Health Series is devoted to the metabolic assessment and support of optimal nutrition in the critically ill patient. An evidence-based review is presented featuring current knowledge of the mechanics for nourishing the critically ill with the metabolic and immunological impact of various nutrition support strategies. Critical care providers or those in aligned subspecialties including members of nutrition support teams are an appropriate audience for this book." (David J. Dries, Doody's Book Reviews, July, 2016)
Reihe
Auflage
Sprache
Verlagsort
Verlagsgruppe
Springer International Publishing
Zielgruppe
Für Beruf und Forschung
Professional/practitioner
Illustrationen
Maße
Höhe: 260 mm
Breite: 183 mm
Dicke: 22 mm
Gewicht
ISBN-13
978-3-319-21830-4 (9783319218304)
DOI
10.1007/978-3-319-21831-1
Schweitzer Klassifikation
Dr. Seres is the Director of Medical Nutrition at Columbia University Medical Center. He is one of the few physicians in the country with a primary focus on hospital based nutrition. He supervises the hospital programs in total parenteral nutrition, manages much of the hospital supplementary enteral nutrition, and provides consultation on feeding issues and malnutrition. Dr. Van Way's activities have centered around hemorrhagic shock, and to exploring the basic mechanisms of cell injury during hemorrhagic shock and resuscitation, and to identify changes which produce long-term damage. In the past several years, his research team has carried out basic and clinical studies of the genomic response to shock and injury, and has developed several potential therapeutic agents for the treatment of hemorrhagic shock. Currently, his team is exploring the mechanisms by which cells adjust to the low-oxygen environments which characterize low perfusion states such as septic and hemorrhagic shock.
